Physician

Dean Hugh Stephens, M.D.

According to 2025 Medicare claims, Dean Stephens, M.D. (NPI: 1134256381) practices rheumatology in the Hilton Head Island-Bluffton-Port Royal, SC market, with the plurality of this provider's patient population coming from Beaufort, SC. This provider's primary affiliated billing organization is SOUTHEASTERN RHEUMATOLOGY ALLIANCE (NPI: 1114795663; TIN: 933460719) and primary practice location at 31404-6234. Stephens is affiliated with the Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Stephens' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 769 traditional Medicare patients, billed 233,316 HCPCS/CPT codes, and received $2,646,398 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 3,016 prescription claims across 532 beneficiaries totaling $2,692,721 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2021 DME data shows 23 claims. Open Payments data shows 88 records totaling $1,969. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $129,444 to $2,646,398. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $201 and ending at $1,100.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	395	11,772	$129,444
2016	403	7,586	$120,050
2017	420	14,181	$319,471
2018	394	88,961	$2,098,527
2019	425	116,509	$2,858,917
2020	467	134,048	$3,128,045
2021	518	163,570	$3,187,555
2022	501	194,469	$4,005,637
2023	480	217,243	$3,432,400
2024	769	233,316	$2,646,398

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	442	4,957	$2,244,673
2016	467	5,110	$2,864,260
2017	488	4,944	$3,097,605
2018	462	4,439	$2,679,914
2019	452	4,123	$2,255,047
2020	502	3,992	$2,543,397
2021	539	3,755	$2,814,852
2022	473	3,433	$3,098,358
2023	466	3,443	$3,123,074
2024	532	3,016	$2,692,721

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$111
2019	N/R	11	$259
2020	N/R	N/R	N/R
2021	N/R	23	$2,033
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	294	907	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	557	946	$93
80053	Blood test, comprehensive group of blood chemicals	233	284	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	231	274	$7
85652	Red blood cell sedimentation rate, to detect inflammation, automated	231	276	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	72	2,272	$651,932
Orencia Clickject	Abatacept	50	1,400	$294,077
Cimzia (2 Pack)	Certolizumab Pegol	32	952	$193,175
Enbrel	Etanercept	22	728	$188,657
Simponi	Golimumab	21	668	$139,055

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	88	$1,969	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dean Hugh Stephens, M.D.?

Tedicare shows public-source Medicare data for Dean Hugh Stephens, M.D. (NPI 1134256381), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dean Hugh Stephens, M.D. have ACO affiliation data?

Dean Hugh Stephens, M.D. is shown with ACO affiliation data for Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to Dean Hugh Stephens, M.D.?

Dean Hugh Stephens, M.D. is linked to SOUTHEASTERN RHEUMATOLOGY ALLIANCE (billing NPI 1114795663) in the available physician profile data.

Does Dean Hugh Stephens, M.D. have Open Payments data?

Dean Hugh Stephens, M.D. has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.